AR025049A1 - CICLOOXIGENASA-1 (COX-1) AND CICLOOXIGENASA-2 (COX-2) CANINES. - Google Patents

CICLOOXIGENASA-1 (COX-1) AND CICLOOXIGENASA-2 (COX-2) CANINES.

Info

Publication number
AR025049A1
AR025049A1 ARP000104048A ARP000104048A AR025049A1 AR 025049 A1 AR025049 A1 AR 025049A1 AR P000104048 A ARP000104048 A AR P000104048A AR P000104048 A ARP000104048 A AR P000104048A AR 025049 A1 AR025049 A1 AR 025049A1
Authority
AR
Argentina
Prior art keywords
cox
ciclooxigenasa
canines
canine
genes
Prior art date
Application number
ARP000104048A
Other languages
Spanish (es)
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Publication of AR025049A1 publication Critical patent/AR025049A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083—Miscellaneous (1.14.99)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Se relaciona con genes que codifican las enzimas proteicas ciclooxigenasa-1 (COX-1) y la ciclooxigenasa-2 (COX-2) caninas, proteínas COX-1 y COX-2 caninas,y ensayos para la evaluacion de las actividades de COX-1 y COX-2 caninas. También se relacionacon moléculas de ácido nucleico asociadas con estos genes queincluyen sus complementos, homologos y fragmentos, y los métodos de utilizacion de estas moléculas de ácido nucleico, las enzimas y los fragmentos de ambas.It is related to genes that encode the canine cyclooxygenase-1 (COX-1) and canine cyclooxygenase-2 (COX-2) protein enzymes, canine COX-1 and COX-2 proteins, and assays for the evaluation of COX- activities 1 and COX-2 canines. It is also related to nucleic acid molecules associated with these genes that include their complements, homologs and fragments, and the methods of using these nucleic acid molecules, enzymes and fragments of both.

ARP000104048A 1999-08-06 2000-08-04 CICLOOXIGENASA-1 (COX-1) AND CICLOOXIGENASA-2 (COX-2) CANINES. AR025049A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14760199P 1999-08-06 1999-08-06

Publications (1)

Publication Number Publication Date
AR025049A1 true AR025049A1 (en) 2002-11-06

Family

ID=22522196

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000104048A AR025049A1 (en) 1999-08-06 2000-08-04 CICLOOXIGENASA-1 (COX-1) AND CICLOOXIGENASA-2 (COX-2) CANINES.

Country Status (6)

Country Link
AR (1) AR025049A1 (en)
AU (1) AU6606500A (en)
CO (1) CO5280149A1 (en)
PE (1) PE20010691A1 (en)
UY (1) UY26279A1 (en)
WO (1) WO2001011026A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002006452A2 (en) 2000-07-18 2002-01-24 National Research Council Of Canada Cloning, sequencing and expression of a comamonas cyclopentanone 1,2-monooxygenase-encoding gene in escherichia coli
EP1463806B1 (en) * 2001-09-28 2011-01-05 Brigham Young University Novel cyclooxygenase variants and methods of use
US7729863B2 (en) 2003-12-17 2010-06-01 Fred Hutchinson Cancer Research Center Methods and materials for canine breed identification
AU2009208035B2 (en) * 2008-01-22 2014-04-03 Dogenes Inc. Compositions and methods for detecting Juvenile Renal Dysplasia or calcium oxalate stones in dogs

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994006919A2 (en) * 1992-09-22 1994-03-31 University Of Rochester Stably-transformed mammalian cells expressing a regulated, inflammatory cyclooxygenase
US5543297A (en) * 1992-12-22 1996-08-06 Merck Frosst Canada, Inc. Human cyclooxygenase-2 cDNA and assays for evaluating cyclooxygenase-2 activity
WO1996040720A1 (en) * 1995-06-07 1996-12-19 University Of Rochester Mammalian prostaglandin h synthase-2

Also Published As

Publication number Publication date
PE20010691A1 (en) 2001-06-27
UY26279A1 (en) 2000-12-29
CO5280149A1 (en) 2003-05-30
AU6606500A (en) 2001-03-05
WO2001011026A9 (en) 2002-07-25
WO2001011026A1 (en) 2001-02-15

Similar Documents

Publication Publication Date Title
Shenk Transcriptional control regions: nucleotide sequence requirements for initiation by RNA polymerase II and III
BR112022021789A2 (en) CORONAVIRUS VARIANT NUCLEIC ACID LIBRARIES
ATE414149T1 (en) SURVIVIN, A PROTEIN THAT INHIBITS CELLULAR APOPTOSIS AND ITS MODULATION
AR021139A1 (en) NUCLEIC ACIDS AND POLIPEPTIDES OF TRANSCRIPTION ACTIVATORS AND METHODS OF USE OF THE SAME
DE69942459D1 (en) ISOLATED NUCLEIC ACID MOLECULES COPYING T CELLS INDUCIBLE FACTORS (TIF), ENCODING PROTEINS AND THEIR USE
PT990047E (en) METHODS AND COMPOSITIONS FOR THE ANALYSIS OF NUCLEIC ACIDS BY MASS SPECTROSCOPY.
CY1115634T1 (en) OSTEOPROTEGERINE COMPONENTS OPTIONAL OPTIONAL CONNECTION
ATE332368T1 (en) SELECTION OF PROTEINS USING RNA-PROTEIN FUSIONS
CR6538A (en) HUMAN ANTIBODIES, RECOMBINANT ANTI-AVB3, NUCLEIC ACIDS CODING THE SAME AND METHOD OF USE
CY1105895T1 (en) SOLUBLE INTEPLEUKIN-6 RECEPTOR/BINDER CHIMERIC PROTEIN, THEREOF AND USES THEREOF
BR0114978A (en) Compositions and methods that are useful in treating inflammatory, metabolic, and proliferative cell conditions or diseases.
BR0107661A (en) Antibodies to human il-1 / ß
CY1105027T1 (en) INHIBITORS OF ENDOPEROXIDE OR PROSTAGLANDIN BIOSYNTHESIS
ATE211174T1 (en) THYMIDINE KINASE MUTANTS
AR026946A1 (en) OSTEOPROTEGERINE / TUMOR NECROSIS FACTORS RECEPTORS
AR016436A1 (en) PROTEIN THAT INHIBITES P27, DNA THAT CODIFIES IT, ANTIBODIES AND PRODUCTS OF DISSOLATION OF THE SAME, NUCLEIC ACID ANTISENTIDE, ARTIFICIAL STRUCTURE OF NUCLEIC ACID AND THE USE OF ALL THIS IN THERAPY AND PROPHYLAXIS OF DISEASE
AR025049A1 (en) CICLOOXIGENASA-1 (COX-1) AND CICLOOXIGENASA-2 (COX-2) CANINES.
ATE286140T1 (en) E. COLI EXTRACT FOR SYNTHESIS OF PROTEINS
DE60139544D1 (en) MODIFIED, FLUORESCENT PROTEINS
DK1082423T3 (en) Cyclin E2 genes and proteins
DE60129809D1 (en) IN VITRO EVOLUTION OF NUCLEIC ACIDS AND CODED POLYPEPTIDES
BRPI0406265B8 (en) method for analysis by capillary electrophoresis, method for research and typing of monoclonal proteins, method of preparation of negatively supercharged modified antibodies and kit for detection and typing of monoclonal proteins
DE69728897D1 (en) SAEUGETIERCHEMOKINE
ATE340257T1 (en) HISTONE DEACETYLASE 9
AR017190A1 (en) METHOD FOR IMPROVING RESISTANCE OR TOLERANCE TO PATHOGENS IN A PLANT THAT INCLUDES INTEGRATING IN THE GENE OF THE SUCH PLANT A GENE THAT CODIFIES A FUSION PROTEIN THAT INCLUDES A FIRST AND SECOND PROTEIN OR DOMAIN OF PROTEIN WITH ANTIPATOGENIC, ANTIPATOGENIC DNA, PROTEINADE